compounded semaglutide law ๐จ A major lawsuit just escalated pressure on GLP-1s in Med Spas Last week, Novo Nordisk filed suit against telehealth company Hims & Hers over compounded products, signaling intensifying legal CBS News investigation: An unapproved
Description
Hearing impairment can have multiple causes, and timely assessment ensures appropriate diagnosis and management
M., & Hudson, J
In older people, who are already experiencing normal muscle loss due to aging, losing too much muscle mass could potentially reduce mobility and increase the risk of falls
Pivoting back to the obesity space, a year-long Phase 2 study comparing semaglutide daily to 0.6 mg of liraglutide daily and placebo demonstrated the superiority of semaglutide over liraglutide in all doses above 0.2 mg (NCT02453711)
Stay tuned as we continue to track the rapidly evolving science on GLP-1s and brain health
The weight loss from GLP-1 agonism derives from appetite suppression and possibly enhanced satiety signals
